Management Strategies for COVID-19 in the General Ward of Cardiovascular Surgery: Experience From a Single Tertiary Hospital in China

Authors

  • Siyi He Department of Cardiovascular Surgery, General Hospital of Western Theater Command, Chengdu, China
  • Xiaoyan Liu Department of Cardiovascular Surgery, General Hospital of Western Theater Command, Chengdu, China
  • Xia Li Department of Cardiovascular Surgery, General Hospital of Western Theater Command, Chengdu, China
  • Xiumei Gao Department of Cardiovascular Surgery, General Hospital of Western Theater Command, Chengdu, China
  • Yushan Liu Department of Cardiovascular Surgery, General Hospital of Western Theater Command, Chengdu, China
  • Liang Hu Department of Cardiovascular Surgery, General Hospital of Western Theater Command, Chengdu, China
  • Lu Chen Department of Cardiovascular Surgery, General Hospital of Western Theater Command, Chengdu, China
  • Hui Jiang Department of Cardiovascular Surgery, General Hospital of Western Theater Command, Chengdu, China
  • Jinbao Zhang Department of Cardiovascular Surgery, General Hospital of Western Theater Command, Chengdu, China
  • Jingwen Li Department of Hospital-Acquired Infection Management, West China Hospital, Sichuan University, Chengdu, China

DOI:

https://doi.org/10.1532/hsf.4151

Keywords:

COVID-19, cardiovascular surgery, general ward, management strategies

Abstract

Coronavirus disease 2019 (COVID-19) is a highly contagious respiratory disease that threatens global health. During the pandemic period of COVID-19, the task for prevention in the general ward of cardiovascular surgery is fairly arduous. The present study intends to summarize our experience with infection control, including ward setting, admission procedures, personnel management, health education, and so on, to provide references for clinical management.

References

Callaway E. 2021. Delta coronavirus variant: scientists brace for impact. Nature.

Creech CB, Walker SC, Samuels RJ. 2021. SARS-CoV-2 Vaccines. Jama 325(13):1318-20.

Deng Y, Hou L, Xu Q, et al. 2020. Cardiopulmonary Bypass Induces Acute Lung Injury via the High-Mobility Group Box 1/Toll-Like Receptor 4 Pathway. Disease markers 2020:8854700.

Dhama K, Khan S, Tiwari R, et al. 2020. Coronavirus Disease 2019-COVID-19. Clinical microbiology reviews 33(4).

Hu B, Guo H, Zhou P, Shi ZL. 2021. Characteristics of SARS-CoV-2 and COVID-19. Nature reviews Microbiology 19(3):141-54.

Kirby T. 2021. New variant of SARS-CoV-2 in UK causes surge of COVID-19. The Lancet Respiratory medicine 9(2):e20-e1.

Su S, Du L, Jiang S. 2021. Learning from the past: development of safe and effective COVID-19 vaccines. Nature reviews Microbiology 19(3):211-9.

Published

2021-10-21

How to Cite

He, S., Liu, X., Li, X., Gao, X., Liu, Y., Hu, L., Chen, L., Jiang, H., Zhang, J., & Li, J. (2021). Management Strategies for COVID-19 in the General Ward of Cardiovascular Surgery: Experience From a Single Tertiary Hospital in China. The Heart Surgery Forum, 24(5), E906-E908. https://doi.org/10.1532/hsf.4151

Issue

Section

Article